Table 3.
Influence of celecoxib and piroxicam on oral cancer invasion score in rats treated with NQO
| Number (%) with lesion invasion score* |
|||||
|---|---|---|---|---|---|
| Group | Agent | Agent Dose (mg/kg diet) |
+1 Invasion | +2 Invasion | +3 Invasion |
| 1 | None (Control) | -- | 3/27 (11) | 6/27 (22) | 17/27 (63) |
| 2 | Celecoxib | 500 | 7/27 (26) | 2/27 (7) | 10/27 (37)† |
| 3 | Celecoxib | 1500 | 5/28 (18) | 12/28 (43) | 4/28 (14)† |
| 4 | Piroxicam | 50 | 4/28 (14) | 8/28 (29) | 11/28 (39)‡ |
| 5 | Piroxicam | 150 | 8/29 (28) | 8/29 (28) | 8/29 (28)† |
| 6 | Zileuton | 2000 | 3/25 (12) | 4/25 (16) | 17/25 (68) |
- +1: extension through the mucosal epithelial basement membrane and into lamina propria only.
- +2: extension into the upper muscle layers.
- +3: extensive infiltration into the underlying muscle.
p < 0.01 versus dietary control group.
0.05 < p < 0.10 versus dietary control group.